Trefoil factor 3 (TFF3)

A promising indicator for diagnosing thyroid follicular carcinoma

Toru Takano, Hiroya Yamada

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Since the introduction of fine needle aspiration biopsy (FNAB) in the 1970's, a preoperative diagnostic technique for thyroid follicular carcinoma has long been awaited. Many markers that distinguish follicular carcinomas from adenomas have been reported; however, most of them have not been confirmed to be beneficial for clinical use. Trefoil factor 3 (TFF3) is a relatively new family of peptides that bears the three-loop trefoil domain. Several groups have reported that the suppression of TFF3 mRNA expression is related to malignant characteristics of thyroid follicular cell- derived tumors and the expression level of TFF3 mRNA is the most promising indicator for diagnosing follicular carcinoma. Development of 7F.F.3-based diagnostic methods is now ongoing and it may not be long before thyroid follicular carcinoma can be diagnosed preoperatively using an aspirated sample from the tumor.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
JournalEndocrine Journal
Volume56
Issue number1
DOIs
Publication statusPublished - 24-03-2009

Fingerprint

Follicular Adenocarcinoma
Carcinoma
Messenger RNA
Fine Needle Biopsy
Adenoma
Neoplasms
Peptides
Trefoil Factor-3

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{5a51b3df60074eadb8adeddc367275bc,
title = "Trefoil factor 3 (TFF3): A promising indicator for diagnosing thyroid follicular carcinoma",
abstract = "Since the introduction of fine needle aspiration biopsy (FNAB) in the 1970's, a preoperative diagnostic technique for thyroid follicular carcinoma has long been awaited. Many markers that distinguish follicular carcinomas from adenomas have been reported; however, most of them have not been confirmed to be beneficial for clinical use. Trefoil factor 3 (TFF3) is a relatively new family of peptides that bears the three-loop trefoil domain. Several groups have reported that the suppression of TFF3 mRNA expression is related to malignant characteristics of thyroid follicular cell- derived tumors and the expression level of TFF3 mRNA is the most promising indicator for diagnosing follicular carcinoma. Development of 7F.F.3-based diagnostic methods is now ongoing and it may not be long before thyroid follicular carcinoma can be diagnosed preoperatively using an aspirated sample from the tumor.",
author = "Toru Takano and Hiroya Yamada",
year = "2009",
month = "3",
day = "24",
doi = "10.1507/endocrj.K08E-105",
language = "English",
volume = "56",
pages = "9--16",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "1",

}

Trefoil factor 3 (TFF3) : A promising indicator for diagnosing thyroid follicular carcinoma. / Takano, Toru; Yamada, Hiroya.

In: Endocrine Journal, Vol. 56, No. 1, 24.03.2009, p. 9-16.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Trefoil factor 3 (TFF3)

T2 - A promising indicator for diagnosing thyroid follicular carcinoma

AU - Takano, Toru

AU - Yamada, Hiroya

PY - 2009/3/24

Y1 - 2009/3/24

N2 - Since the introduction of fine needle aspiration biopsy (FNAB) in the 1970's, a preoperative diagnostic technique for thyroid follicular carcinoma has long been awaited. Many markers that distinguish follicular carcinomas from adenomas have been reported; however, most of them have not been confirmed to be beneficial for clinical use. Trefoil factor 3 (TFF3) is a relatively new family of peptides that bears the three-loop trefoil domain. Several groups have reported that the suppression of TFF3 mRNA expression is related to malignant characteristics of thyroid follicular cell- derived tumors and the expression level of TFF3 mRNA is the most promising indicator for diagnosing follicular carcinoma. Development of 7F.F.3-based diagnostic methods is now ongoing and it may not be long before thyroid follicular carcinoma can be diagnosed preoperatively using an aspirated sample from the tumor.

AB - Since the introduction of fine needle aspiration biopsy (FNAB) in the 1970's, a preoperative diagnostic technique for thyroid follicular carcinoma has long been awaited. Many markers that distinguish follicular carcinomas from adenomas have been reported; however, most of them have not been confirmed to be beneficial for clinical use. Trefoil factor 3 (TFF3) is a relatively new family of peptides that bears the three-loop trefoil domain. Several groups have reported that the suppression of TFF3 mRNA expression is related to malignant characteristics of thyroid follicular cell- derived tumors and the expression level of TFF3 mRNA is the most promising indicator for diagnosing follicular carcinoma. Development of 7F.F.3-based diagnostic methods is now ongoing and it may not be long before thyroid follicular carcinoma can be diagnosed preoperatively using an aspirated sample from the tumor.

UR - http://www.scopus.com/inward/record.url?scp=62549143140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549143140&partnerID=8YFLogxK

U2 - 10.1507/endocrj.K08E-105

DO - 10.1507/endocrj.K08E-105

M3 - Review article

VL - 56

SP - 9

EP - 16

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 1

ER -